Ropes & Gray Represents EQRx in Partnership with Abdul Latif Jameel Health to Commercialize Oncology Programs in Middle East, Turkey and Africa

In The News
November 23, 2021

Ropes & Gray advised EQRx in a strategic collaboration with Abdul Latif Jameel Health, part of the international diversified family business of Abdul Latif Jameel. The transaction was announced on November 22. 

Under the agreement, Abdul Latif Jameel Health will become EQRx’s regulatory and commercial partner for two of EQRx’s oncology programs, aumolertinib and sugemalimab, in selected markets throughout the Middle East region, Turkey and all of Africa. 

The Ropes & Gray team was led by life sciences partner Abigail Gregor (Boston).